Catalyst Wire Dossier Catalyst Wire Dossier

Sulpegfilgrastim

sulpegfilgrastim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sulpegfilgrastim, covering 2025-06-12 to 2025-06-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study on the Use of Sulpegfilgrastim to Prevent the Incidence of Neutropenia With Infection in Newly Diagnosed Non-transplant Multiple Myeloma Patients [NA]

See pricing